Gotwals Philip J — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Gotwals Philip J has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Profile
Philip J. Gotwals is associated with Capricor Therapeutics, Inc. (CAPR) per SEC insider filing as of 2026-01-07 (CIK 0001982655). The filing lists him with no reported insider purchases or sales and does not disclose a specific role. Capricor is a clinical-stage biotechnology company focused on cell- and exosome-based therapeutics for Duchenne muscular dystrophy and related diseases.
Role
Director
Notability
35/100
Board memberships
Capricor Therapeutics, Inc.
Awards & honors
Listed as an insider in Capricor Therapeutics' SEC filing (CIK 0001982655)
Philip J. Gotwals is associated with Capricor Therapeutics, Inc. (CAPR) per SEC insider filing as of 2026-01-07 (CIK 0001982655). The filing lists him with no reported insider purchases or sales and does not disclose a specific role. Capricor is a clinical-stage biotechnology company focused on cell- and exosome-based therapeutics for Duchenne muscular dystrophy and related dis…
How many SEC Form 4 filings has Gotwals Philip J submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Gotwals Philip J's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
